ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 18547417

Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.

Westgaard A and 7 others. BMC Cancer, 2008. Cited by 181 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. Papers, record 18547417. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18547417

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
PubMed
Journal
BMC Cancer
PubMed
Year
2008
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
181
iCite
Relative citation ratio, by iCite
4.94
iCite
Revised in PubMed
2024-04-14
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Westgaard AArne
2Tafjord SSvetlana
3Farstad INInger N
4Cvancarova MMilada
5Eide TJTor J
6Mathisen OOystein
7Clausen OPOle Petter F
8Gladhaug IPIvar P

Source PubMed

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Ampulla of VaterMajor topic
Pancreatic DuctsMajor topic
Pancreatic NeoplasmsMajor topic
Aged
Biopsy, Needle
Case-Control Studies
Cell Differentiation
Common Bile Duct Neoplasms
Female
Humans
Immunohistochemistry
Male
Middle Aged
Multivariate Analysis
Neoplasm Invasiveness
Pancreatectomy
Pancreaticoduodenectomy
Probability
Prognosis
Proportional Hazards Models
Retrospective Studies
Risk Assessment
Survival Analysis
Treatment Outcome

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117,240,300Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas.Ann Diagn Pathol2007https://conductscience.org/library/papers/17240300PubMed
22,644,853The gross anatomy and histology of the gallbladder, extrahepatic bile ducts, Vaterian system, and minor papilla.Am J Surg Pathol1989https://conductscience.org/library/papers/2644853PubMed
311,029,493p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.Int J Oncol2000https://conductscience.org/library/papers/11029493PubMed
415,710,987Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.Gut2005https://conductscience.org/library/papers/15710987PubMed
59,637,545Periampullary adenocarcinoma: analysis of 5-year survivors.Ann Surg1998https://conductscience.org/library/papers/9637545PubMed
68,182,763Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.J Natl Cancer Inst1994https://conductscience.org/library/papers/8182763PubMed
79,671,071Factors predictive of survival in ampullary carcinoma.Ann Surg1998https://conductscience.org/library/papers/9671071PubMed
811,520,088Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.Eur J Surg Oncol2001https://conductscience.org/library/papers/11520088PubMed
910,449,973
Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardized pathological staging of pancreaticoduodenectomy specimens including a checklist.
Dig Surg1999https://conductscience.org/library/papers/10449973PubMed
107,511,574Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.Jpn J Cancer Res1994https://conductscience.org/library/papers/7511574PubMed

1 to 10 of 16

See all 16 references

Cited by105

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 181 citations.

PMIDTitleJournalYearIn PapersSource
42,423,293Optimizing postoperative prognostication in duodenal adenocarcinoma: a multicenter study with external validation.Oncologist2026https://conductscience.org/library/papers/42423293PubMed
42,326,281Large-Cell Neuroendocrine Carcinoma of the Ampulla of Vater: A Systematic Literature Review of a Rare and Aggressive Entity.Cureus2026https://conductscience.org/library/papers/42326281PubMed
42,122,231The Role of the Mesopancreas in Periampullary Malignancies.Cancers (Basel)2026https://conductscience.org/library/papers/42122231PubMed
42,062,927Development and internal validation of a clinical-CT model for differentiating intestinal-type from pancreatobiliary-type periampullary carcinoma.BMC Gastroenterol2026https://conductscience.org/library/papers/42062927PubMed
41,990,295Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary Carcinoma.JCO Precis Oncol2026https://conductscience.org/library/papers/41990295PubMed
41,969,558Association of pre-drainage bilirubin levels and pathological features with survival in patients undergoing preoperative biliary drainage: a single-center retrospective study.Transl Gastroenterol Hepatol2026https://conductscience.org/library/papers/41969558PubMed
41,694,497Twenty-year temporal trends, risk profiles, and prognostic value of clinicopathological features in gallbladder cancer following cholecystectomy.World J Gastroenterol2026https://conductscience.org/library/papers/41694497PubMed
41,301,018Evaluating the Role of Morphological Subtypes in the Classification of Periampullary Adenocarcinomas.Cancers (Basel)2025https://conductscience.org/library/papers/41301018PubMed
41,180,030Advanced intestinal-type ampullary cancer successfully treated using combination therapy with gemcitabine, cisplatin, and durvalumab: A case report.SAGE Open Med Case Rep2025https://conductscience.org/library/papers/41180030PubMed
40,940,827FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG).Cancers (Basel)2025https://conductscience.org/library/papers/40940827PubMed

1 to 10 of 105

See all 105 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TENM110,178PubTator's text mininghttps://conductscience.org/library/genes/10178

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18547417

GET https://conductscience.org/api/papers/v1/18547417/cited_by?page=2

API referenceFor AI assistants